With the lastest COVID-19 vaccine gaining and Emergency Use Authorization from the FDA, many pharmacists are looking for more information about how adenovirus-based vaccines work. Join us for this episode of our 15 on COVID-19 series as we explore the mechanism of action of adenovirus-based vaccines, review the answers to some common questions you may be receving about the latest COVID-19 vaccine, and take a look at some of the challenges and lessons learned over the last 30 years during the development of adenovirus-based vaccine platforms.
- Discuss the latest developments related to COVID-19
Activity type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 0.25 contact hour of CPE credit (0.025 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-147-H06-P/T
To obtain credit for completing 15 on COVID-19 for 03/03/2021 - Adenovirus Vaccine Technology, participants will need to watch the archived webinar, complete the assessment, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: March 3, 2021
Expiration date: March 3, 2022 - No credit granted after this date
15 on COVID-19 for 03/03/2021 - Adenovirus Vaccine Technology is an activity for pharmacists and pharamacy technicians developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Daniel Zlott, PharmD, BCOP and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-147-H06-P||0.025 CEUs||March 03, 2021 - March 03, 2022|
|ACPE# 0202-0000-21-147-H06-T||0.025 CEUs||March 03, 2021 - March 03, 2022|